FDA Inspection 808008 — Carter BloodCare

Carter BloodCare — FEI 3000717800

The FDA completed an inspection of Carter BloodCare on Nov 16, 2012 in Flower Mound, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 16, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Flower Mound, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.